The U.S. Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

Honda and Nissan begin merger talks with a plan for the combination to be completed in 2026, Qualcomm scores a victory in its ...

Two U.S. Navy pilots ejected from their jet fighter over the Red Sea after being caught in "an apparent case of friendly-fire," U.S. Central Command said Sunday, as American forces conducted a new ...

In another milestone, Eli Lilly's weight-loss medication, Zepbound, received FDA approval, marking it as the first drug to specifically tackle moderate to severe obstructive sleep apnea in obese ...

Already established as cornerstone therapies in diabetes and obesity, GLP-1 receptor agonists have now cracked into the ...

Zepbound is Eli Lilly’s weight loss drug. Now, it is also a drug to treat obstructive sleep apnea (OSA).The U.S. Food and ...

Zepbound, from drugmaker Eli Lilly, is already approved for people who are obese or overweight and have a related health condition, such as type 2 diabetes, high cholesterol or high blood ...

“Semaglutide is expected to be approved for chronic kidney disease by next year and tirzepatide for obstructive sleep apnea and cardiovascular risk ... drug from Health Canada in June 2022, and the ...

Zepbound, a popular weight loss drug, has become the first FDA-approved prescription medication to treat obstructive sleep ...

And here’s what else you need to know to Start Your Week Smart . Your day is busy. 5 Things is your one-stop shop for the ...